See also this year's filing and all EDGAR filings for this company.
PDF Report 0001677077_2025_Alzamend_Neuro_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001677077, Alzamend Neuro Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 455,242 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 176,346 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,225,773 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,152,995 |
| 9 | ResearchAndDevelopmentExpense | 5,900,055 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -9,486 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 631,588 |
| 1 | Liabilities | 3,225,773 |
| 2 | Expenses | 9,053,050 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -2,594,185 |
| 5 | NetIncome | -9,062,536 |
| 6 | ComprehensiveNetIncome | -9,062,536 |
| 7 | BaseVar | 6,459,948 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -7.63 |
| 9 | EconomicCapitalRatio | 0.0134 |
Edgar->Model Mapping
Feature Distribution
Change over Time
